Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00000381Phase 3Completed
A Phase 3 trial of fluoxetine in generalized anxiety disorder (GAD), sponsored by University of Pittsburgh. Started Jun 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00000381.